InvestorsObserver
×
News Home

Should You Add Aridis Pharmaceuticals Inc (ARDS) Stock to Your Portfolio Tuesday?

Tuesday, July 27, 2021 11:09 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Aridis Pharmaceuticals Inc (ARDS) Stock to Your Portfolio Tuesday?

Aridis Pharmaceuticals Inc (ARDS) is around the middle of the Healthcare sector according to InvestorsObserver. ARDS received an overall rating of 4, which means that it scores higher than 4% of stocks. Additionally, Aridis Pharmaceuticals Inc scored a 60 in the Healthcare sector, ranking it higher than 60% of stocks in that sector.

Overall Score - 4
ARDS has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on ARDS!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Aridis Pharmaceuticals Inc Stock Today?

Aridis Pharmaceuticals Inc (ARDS) stock is trading at $4.77 as of 11:08 AM on Tuesday, Jul 27, a loss of -$0.31, or -6.1% from the previous closing price of $5.08. The stock has traded between $4.60 and $5.11 so far today. Volume today is less active than usual. So far 137,059 shares have traded compared to average volume of 258,112 shares. Click Here to get the full Stock Report for Aridis Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App